CHICAGO, April 30, 2021 /PRNewswire/ — According to the new market research report “Cancer Diagnostics Market by Product (Consumables (Anitibodies, Probes), Instruments (Pathology Instruments, Imaging Instruments, Biopsy), Technology (IVD Testing), Application (Breast Cancer, Lung Cancer), End User (Hospitals) – Global Forecasts to 2026″, published by MarketsandMarkets™, the global Cancer Diagnostics Market size is projected to reach USD 26.6 billion by 2026 from USD 17.2 billion in 2021, at a CAGR of 11.5%.
Browse in-depth TOC on “Cancer Diagnostics Market”
300 – Tables
48 – Figures
280 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186559121
The growth in this market is attributed to the increasing incidence of cancer and increasing number of private diagnostic laboratories.
Consumables accounted for the larger share of the cancer diagnostics market in 2020
Based on the product, the market is segmented into consumables and instruments. In 2020, the instruments segment accounted for the larger share of the market. The large share of this segment can be attributed to the increasing incidence of cancer and increasing number of cancer diagnostics test.
By technology, the IVD testing segment accounted for the largest market share in 2020
Based on the technology, the market is segmented into IVD testing, imaging based technique and biopsy technique. The IVD testing segment accounted for the largest market share in 2020. The…
